UNITED THERAPEUTICS Corp Quarterly Marketable Securities, Current in USD from Q4 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
UNITED THERAPEUTICS Corp quarterly Marketable Securities, Current history and growth rate from Q4 2016 to Q2 2024.
  • UNITED THERAPEUTICS Corp Marketable Securities, Current for the quarter ending June 30, 2024 was $1.62B, a 0.25% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.62B +$4.1M +0.25% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $1.46B -$244M -14.3% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $1.79B -$91.1M -4.85% Dec 31, 2023 10-Q 2024-07-31
Q3 2023 $1.77B +$119M +7.22% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $1.61B +$152M +10.4% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $1.7B +$246M +16.9% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $1.88B +$842M +81.2% Dec 31, 2022 10-K 2024-02-21
Q3 2022 $1.65B +$557M +51% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $1.46B +$435M +42.4% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $1.45B +$555M +61.8% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $1.04B -$60.4M -5.51% Dec 31, 2021 10-K 2023-02-22
Q3 2021 $1.09B +$182M +19.9% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $1.03B +$150M +17.1% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $899M +$230M +34.3% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $1.1B +$349M +46.7% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $910M +$60M +7.06% Sep 30, 2020 10-Q 2020-10-28
Q2 2020 $875M -$29.6M -3.27% Jun 30, 2020 10-Q 2020-07-29
Q1 2020 $669M -$145M -17.8% Mar 31, 2020 10-Q 2020-04-29
Q4 2019 $748M +$800K +0.11% Dec 31, 2019 10-K 2021-02-24
Q3 2019 $850M +$269M +46.2% Sep 30, 2019 10-Q 2019-10-30
Q2 2019 $905M +$438M +93.7% Jun 30, 2019 10-Q 2019-07-31
Q1 2019 $815M +$490M +151% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $747M +$524M +236% Dec 31, 2018 10-K 2020-02-26
Q3 2018 $582M +$438M +306% Sep 30, 2018 10-Q 2018-10-31
Q2 2018 $467M +$358M +327% Jun 30, 2018 10-Q 2018-08-01
Q1 2018 $324M +$290M +862% Mar 31, 2018 10-Q 2018-05-02
Q4 2017 $222M +$195M +700% Dec 31, 2017 10-K 2019-02-27
Q3 2017 $143M Sep 30, 2017 10-Q 2017-10-25
Q2 2017 $109M Jun 30, 2017 10-Q 2017-07-27
Q1 2017 $33.7M Mar 31, 2017 10-Q 2017-04-26
Q4 2016 $27.8M Dec 31, 2016 10-K 2018-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.